You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xeloda (Capecitabine)

Showing 26 - 50 of 1,514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

Recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • New York, New York
    Bureau for Cancer Research
May 10, 2023

Anal Squamous Cell Carcinoma Trial in New York (Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and

Recruiting
  • Anal Squamous Cell Carcinoma
  • Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Apr 27, 2023

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
Has Results
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,

Terminated
  • Rectal Mucinous Adenocarcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Colorectal Tumors Trial in Heidelberg (Capecitabine, 131I-huA33 (131-Iodine on humanised mAb A33))

Completed
Has Results
  • Colorectal Neoplasms
  • Capecitabine
  • 131I-huA33 (131-Iodine on humanised monoclonal antibody A33)
  • Heidelberg, Victoria, Australia
    Ludwig Institute Oncology Unit and Tumor Targeting Program, Aust
Jan 11, 2022

Gastric Cancer Trial in Shanghai (PLD, Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai General Hospital
Sep 7, 2022

Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Not yet recruiting
  • Recurrent Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 17, 2022

Brain Metastases, Breast Cancer, Metastatic Breast Cancer Trial in Multiple Locations (BKM120, capecitabine, Trastuzumab)

Completed
Has Results
  • Brain Metastases
  • +2 more
  • Multiple Locations, Texas
    Please contact Zuzanne Bristow for list of sites
Jan 31, 2022

Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor

Completed
Has Results
  • Metastatic or Unresectable Solid Tumor Malignancy
  • Fort Myers, Florida
  • +2 more
Feb 15, 2022

Locally Advanced Rectal Cancer Trial (PD-1 inhibitor, Capecitabine, Long-course radiation therapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • PD-1 inhibitor
  • +2 more
  • (no location specified)
Aug 16, 2022

Breast Cancer Trial in Lyon, Saint-herblain (Combination of ribociclib + capecitabine)

Active, not recruiting
  • Breast Cancer
  • Combination of ribociclib + capecitabine
  • Lyon, France
  • +1 more
Mar 8, 2022

Cancer of Pancreas Trial in Cairo (Capecitabine, follow up)

Recruiting
  • Cancer of Pancreas
  • Cairo, Egypt
  • +2 more
Sep 30, 2022

Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

Terminated
  • Breast Neoplasms
  • Malignant Tumor of the Breast
  • Multiple Locations, Texas
    19 Sites
Nov 29, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
Jul 13, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Colon Cancer Trial in Oslo (Capecitabine)

Active, not recruiting
  • Colon Cancer
  • Oslo, Norway
    Oslo University Hospital
Apr 19, 2022

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Cleveland (CB-839, Capecitabine)

Active, not recruiting
  • Colorectal Cancer
  • +3 more
  • Cleveland, Ohio
  • +1 more
Jan 14, 2022

Rectal Cancer Trial in Switzerland (drug, radiation, procedure)

Terminated
  • Rectal Cancer
  • Basel, Switzerland
  • +6 more
Jan 14, 2022

Locally Advanced Rectal Cancer Trial in Miami (Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Intensity-modulated radiation therapy
  • +5 more
  • Miami, Florida
    University of Miami
Oct 28, 2022

Carcinoma Trial in Saint Louis (Intraperitoneal Oxaliplatin, Bevacizumab, Capecitabine)

Active, not recruiting
  • Carcinoma
  • Intraperitoneal Oxaliplatin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2021

Triple Negative Breast Cancer Trial in Washington, Chicago, Hackensack (Nivolumab, Capecitabine)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +3 more
Mar 14, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +5 more
Jan 12, 2023

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022